America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Michael
M
Bretthauer
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Michal F
MF
Kaminski
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Cesare
C
Hassan
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Mette
M
Kalager
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Øyvind
Ø
Holme
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Geir
G
Hoff
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Magnus
M
Løberg
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Jaroslaw
J
Regula
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Antoni
A
Castells
From University of Oslo, Oslo University Hospital, and Cancer Registry of Norway, Oslo, Norway; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Nuovo Regina Margherita Hospital, Rome, Italy; Sørlandet Hospital, Kristiansand, Norway; Telemark Hospital, Skien, Norway; Hospital Clínic, Barcelona, Spain; and Karolinska Institutet, Stockholm, Sweden.
Hans-Olov
HO
Adami
D026683:Advisory Committees; D015179:Colorectal Neoplasms / Q000175:diagnosis*; D055088:Early Detection of Cancer / Q000379:methods / Q000592:standards*; D019317:Evidence-Based Medicine; D006801:Humans; D008403:Mass Screening / Q000379:methods / Q000592:standards*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014481:United States